Fibroids Clinical Trials 2024

Fibroids Clinical Trials 2024

Fibroids research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in fibroids clinical trials today.

Fibroids Clinical Trials

Here are the 0 most popular medical studies for fibroids

Popular filter options for fibroids trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to fibroids

What are the top hospitals conducting fibroids research?

When it comes to clinical trials focused on fibroids, hospitals across different locations are making strides in advancing treatment options for this common condition. In Chandler, the local hospital is actively conducting two trials related to fibroids, demonstrating their commitment to finding innovative solutions. Similarly, Canoga Park's hospital is also investing resources into two ongoing fibroid trials with the aim of improving patient outcomes. Hialeah, Lake Worth, and Miami join these efforts with each of their respective hospitals currently engaged in two active clinical trials focused specifically on fibroids. While none of these hospitals have conducted previous studies in this area as recorded by available data, their dedication towards researching and addressing fibroids showcases a collective determination within the medical community to benefit patients grappling with this condition.

Fibroids are non-cancerous growths that develop in or around the uterus and affect millions of women worldwide. They can vary widely in size and symptoms, ranging from heavy menstrual bleeding and pelvic pain to complications during pregnancy. By conducting these clinical trials dedicated solely to understanding fibroids better and exploring new potential treatments or interventions for patients suffering from them indicate an increasing recognition within medical communities that more research is needed on this prevalent condition affecting women's health.

These hospitals' involvement highlights not only their commitment but also encourages collaborative efforts among healthcare professionals striving towards enhancing knowledge about fibroids while offering hope for those affected by providing access to cutting-edge therapies through participation in ongoing clinical trials. Although there may be no historical records yet regarding completed research projects specifically targeting fibroids at present; however backing such investigations still indicates a promising development which ultimately contributes significantly toward discovering effective treatments for individuals struggling with this often-overlooked ailment impacting countless lives globally

Which are the best cities for fibroids clinical trials?

When it comes to fibroids clinical trials, several cities emerge as leaders in research and development. Miami, Florida boasts 10 active trials focusing on treatments such as Saroglitazar Magnesium 2 mg and Elagolix. Atlanta, Georgia follows closely with 9 ongoing studies centered around interventions like Elagolix and Vilaprisan (BAY1002670). Tucson, Arizona showcases 8 active trials exploring treatment options including Relugolix Combination Therapy and Saroglitazar Magnesium 2 mg. Other notable cities include Houston, Texas with 7 trials underway studying Vilaprisan (BAY1002670) among others, and San Diego, California with a total of 6 active trials investigating various interventions for fibroids. These cities offer individuals afflicted by fibroids access to cutting-edge clinical research that may bring about advancements in care and improved outcomes.

Which are the top treatments for fibroids being explored in clinical trials?

Fibroids, a common condition among women, are currently the subject of various clinical trials exploring potential treatments. One notable contender is Saroglitazar Magnesium 2 mg—a promising drug being tested in one ongoing trial dedicated to fibroids. While its presence may be relatively recent since its first listing in 2021, it holds immense potential for advancing treatment options and improving the lives of individuals affected by this condition. As researchers delve deeper into these trials, they continue to pave the way towards innovative solutions for managing fibroids effectively.

What are the most recent clinical trials for fibroids?

Exciting advancements in fibroid treatment are emerging from recent clinical trials, offering hope and potential breakthroughs for those affected by this condition. One notable trial evaluated the efficacy of a relugolix combination tablet in treating fibroids, reaching Phase 3 and becoming available on 9/14/2023. Additionally, a Phase 3 trial investigated the use of green tea extract as a potential therapy for fibroids with promising results since it became available on 1/5/2023. Another noteworthy study reached Phase 2 and explored Cohort 1's response to an innovative treatment approach for fibroids since its availability on 9/8/2022. As we eagerly await further developments, these trials pave the way towards improved management options for individuals grappling with fibroids.

What fibroids clinical trials were recently completed?

Several recent clinical trials have made significant progress in the field of fibroids. In May 2022, Vertex Pharmaceuticals Incorporated completed a trial for ELX/TEZ/IVA, followed by another completion of the same therapy in January 2022. Nabriva Therapeutics AG also concluded their study on Lefamulin in March 2022. Various other trials were carried out, including ones sponsored by Insmed Incorporated (Brensocatib) and Stanford University (Empagliflozin 10 MG), both completed in November 2021. These advancements showcase ongoing efforts to find innovative treatments for fibroids and offer hope to patients affected by this condition.